<DOC>
	<DOCNO>NCT03064568</DOCNO>
	<brief_summary>Purpose identify misoprostol addition local vasopressin decrease blood loss compare vasopressin alone , current practice time . The study double-blinded neither patient researcher know whether placebo misoprostol give . We monitor patient decrease hemoglobin hematocrit , need transfusion , operative time among measure perioperative morbidity see addition misoprostol make significant difference . We also observe patient see side effect misoprostol make use undesirable .</brief_summary>
	<brief_title>Rectal Misoprostol Hemostatic Agent During Abdominal Myomectomy</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Female age 2050 y/o plan undergo abdominal myomectomy symptomatic myomatous uterus Patient contraindication misoprostol vasopressin , personal history cardiac pulmonary disease , history prior myomectomy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Myomectomy , Misoprostol , Vasopressin , Blood loss</keyword>
</DOC>